StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
GOCO$0.69+7.73%
Fair $0.69+0.0%

GOCO

GoHealth, Inc.

Financial Services / Insurance BrokersNasdaqCM

$0.69

+0.05 (+7.73%)

Fairly Valued+0.0%Fair Value $0.69Fund rank 18/100 · Data gapFallback financials|
SA 5/F
F-Score: 1/9
High DebtLow Profitability

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 0.0/100

Data gap 18/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 16/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

5/100

F

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

20/100

SEC 0%

Latest source: unknownPeriods: 8Warnings: 2unknown: 8
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified. Debt-to-Equity ratio is 7.10, above the 2.0 threshold ROE is -2.7%, below the 5% threshold
Thesis & Journal · GOCOLocal privado en este navegador · GoHealth, Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$20M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-271.3%

↓

Gross Margin

73.4%

↑

Debt/Equity

7.10

↑
52-Week Range$1
$1$7

TradingView lightweight chart

GOCO price, volumen y niveles de valoración

Último $0.689Periodo -99.8%
Fair value: $0.690

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2018–2025 · 7 años de histórico normalizado

Revenue CAGR

—

FCF CAGR

—

FCF margin

-36.0%

FCF / Net income

0.51x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $361.8M · net income $-257.1M · FCF $-130.2M

2018-FY → 2025-FY

Gross margin

73.4%— pts

Operating margin

-42.3%— pts

Net margin

-71.1%— pts

FCF margin

-36.0%— pts
MetricTTM
2025
2024
2023
2022
2021
2020
2019
2018
Income Statement
Revenue$361.8M$361.8M$798.9M$734.7M$631.7M————
Net Income$-257.1M$-257.1M$-2.9M$-63.3M$-148.7M$-189.4M$-44.3M—$28.1M
EBITDA$-333.7M$-333.7M$173.7M$24.1M$-211.5M$-476.0M$-60.0M—$34.9M
EPS——-0.66-7.19-17.72-26.80-3.35——
Gross Margin73.4%73.4%83.7%78.4%70.3%————
Operating Margin-42.3%-42.3%-0.9%-9.4%-44.5%————
Net Margin-71.1%-71.1%-0.4%-8.6%-23.5%————
Balance Sheet
Debt/Equity7.107.101.791.941.751.881.04——
Current Ratio2.032.03———————
Cash Flow
Free Cash Flow$-130.2M$-130.2M$-35.3M$95.4M$47.4M————
Returns
ROE-271.3%-271.3%-1.0%-22.6%-46.8%-53.6%-11.6%——
Valuation
EV/EBITDA——3.6323.92—————
P/B0.120.120.490.440.32————
Growth & Yield
Revenue Growth-54.7%-54.7%8.7%16.3%—————
EPS Growth——90.8%59.4%—-700.0%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -87.5%

Total return

-87.5%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.66 → n/d

Residual

-87.5%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-87.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.